Maria V Golikova

ResearcherID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 18

Top Topics

Mycobacterium Tuberculosis

Klebsiella Pneumoniae

Clinical Evaluation

Multidrug Resistant

Top Venues

Antibiotics (Basel, Switzerland)

Journal of chemotherapy (Florence, Italy)

The Journal of antimicrobial chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Kamilla N Alieva, Maria V Golikova, Stephen H Zinner
Role of volume and inoculum in MIC assessment: a study with meropenem and Klebsiella pneumoniae. The Journal of antimicrobial chemotherapy (2024)
Elena N Strukova, Maria V Golikova, Svetlana A Dovzhenko, Mikhail B Kobrin, Stephen H Zinner
Pharmacodynamics of Doripenem Alone and in Combination with Relebactam in an In Vitro Hollow-Fiber Dynamic Model: Emergence of Resistance of Carbapenemase-Producing Klebsiella pneumoniae and the Inoculum Effect. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Elena N Strukova, Maria V Golikova, Svetlana A Dovzhenko, Mikhail B Kobrin, Stephen H Zinner
Pharmacodynamics of Doripenem Alone and in Combination with Relebactam in an In Vitro Hollow-Fiber Dynamic Model: Emergence of Resistance of Carbapenemase-Producing Klebsiella pneumoniae and the Inoculum Effect. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Kamilla N Alieva, Maria V Golikova, Anastasiya A Kuznetsova, Stephen H Zinner
Fluorescence Microscopy: Determination of Meropenem Activity against Klebsiella pneumoniae . Antibiotics (Basel, Switzerland) 12 (7) (2023)
Maria V Golikova, Kamilla N Alieva, Elena N Strukova, Daria A Kondratieva, Nika F Petrova, Mayya A Petrova, Stephen H Zinner
Comparative Meropenem Pharmacodynamics and Emergence of Resistance against Carbapenem-Susceptible Non-Carbapenemase-Producing and Carbapenemase-Producing Enterobacterales: A Pharmacodynamic Study in a Hollow-Fiber Infection Model. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Maria V Golikova, Kamilla N Alieva, Elena N Strukova, Daria A Kondratieva, Nika F Petrova, Mayya A Petrova, Stephen H Zinner
Comparative Meropenem Pharmacodynamics and Emergence of Resistance against Carbapenem-Susceptible Non-Carbapenemase-Producing and Carbapenemase-Producing Enterobacterales: A Pharmacodynamic Study in a Hollow-Fiber Infection Model. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Maria V Golikova, Elena N Strukova, Kamilla N Alieva, Vladimir A Ageevets, Alisa A Avdeeva, Ofeliia S Sulian, Stephen H Zinner
Meropenem MICs at Standard and High Inocula and Mutant Prevention Concentration Inter-Relations: Comparative Study with Non-Carbapenemase-Producing and OXA-48-, KPC- and NDM-Producing Klebsiella pneumoniae . Antibiotics (Basel, Switzerland) 12 (5) (2023)
Kamilla N Alieva, Maria V Golikova, Svetlana A Dovzhenko, Mikhail B Kobrin, Elena N Strukova, Vladimir A Ageevets, Alisa A Avdeeva, Ofeliia S Sulian, Sergey V Sidorenko, Stephen H Zinner
Testing the mutant selection window hypothesis with meropenem: In vitro model study with OXA-48-producing Klebsiella pneumoniae. PloS one 18 (8) (2023)
Maria V Golikova, Kamilla N Alieva, Alla V Filimonova, Vladimir A Ageevets, Ofeliia S Sulian, Alisa A Avdeeva, Sergey V Sidorenko, Stephen H Zinner
Klebsiella pneumoniae Susceptibility to Carbapenem/Relebactam Combinations: Influence of Inoculum Density and Carbapenem-to-Inhibitor Concentration Ratio. Biomedicines 10 (6) (2022)
Alla V Filimonova, Maria V Golikova, Elena N Strukova, Yury A Portnoy, Anastasiya A Kuznetsova, Stephen H Zinner
Predicting the Effects of Carbapenem/Carbapenemase Inhibitor Combinations against KPC-Producing Klebsiella pneumoniae in Time-Kill Experiments: Alternative versus Traditional Approaches to MIC Determination. Antibiotics (Basel, Switzerland) 10 (12) (2021)
Stephen H Zinner, Kamilla N Alieva, Maria V Golikova, Elena N Strukova, Yury A Portnoy, Alexander A Firsov
Anti-mutant efficacy of antibiotic combinations: in vitro model studies with linezolid and daptomycin. The Journal of antimicrobial chemotherapy 76 (7) (2021)
Maria V Golikova, Elena N Strukova, Yury A Portnoy, Stephen H Zinner, Alexander A Firsov
MPC-Based Prediction of Anti-Mutant Effectiveness of Antibiotic Combinations: In Vitro Model Study with Daptomycin and Gentamicin against Staphylococcus aureus. Antibiotics (Basel, Switzerland) 10 (10) (2021)
Maria V Golikova, Elena N Strukova, Yury A Portnoy, Stephen H Zinner, Alexander A Firsov
Verification of a Novel Approach to Predicting Effects of Antibiotic Combinations: In Vitro Dynamic Model Study with Daptomycin and Gentamicin against Staphylococcus aureus. Antibiotics (Basel, Switzerland) 9 (9) (2020)
Kamilla N Alieva, Maria V Golikova, Yury A Portnoy, Svetlana A Dovzhenko, Mikhail B Kobrin, Stephen H Zinner, Alexander A Firsov
Concentration-dependent enrichment of resistant Enterococcus faecium exposed to linezolid in an in vitro dynamic model. Journal of chemotherapy (Florence, Italy) 30 (6-8) (2019)
Maria V Golikova, Elena N Strukova, Yury A Portnoy, Svetlana A Dovzhenko, Mikhail B Kobrin, Stephen H Zinner, Alexander A Firsov
Resistance studies with Streptococcus pneumoniae using an in vitro dynamic model: amoxicillin versus azithromycin at clinical exposures. Journal of chemotherapy (Florence, Italy) 31 (5) (2019)
Maria V Golikova, Elena N Strukova, Yury A Portnoy, Svetlana A Dovzhenko, Mikhail B Kobrin, Stephen H Zinner, Alexander A Firsov
A novel parameter to predict the effects of antibiotic combinations on the development of Staphylococcus aureus resistance: in vitro model studies at subtherapeutic daptomycin and rifampicin exposures. Journal of chemotherapy (Florence, Italy) (2019)
Maria V Golikova, Elena N Strukova, Yury A Portnoy, Svetlana A Dovzhenko, Mikhail B Kobrin, Stephen H Zinner, Alexander A Firsov
Predicting effects of antibiotic combinations using MICs determined at pharmacokinetically derived concentration ratios: in vitro model studies with linezolid- and rifampicin-exposed Staphylococcus aureus. Journal of chemotherapy (Florence, Italy) 29 (5) (2017)
Alexander A Firsov, Maria V Golikova, Elena N Strukova, Yury A Portnoy, Svetlana A Dovzhenko, Mikhail B Kobrin, Stephen H Zinner
Pharmacokinetically-based prediction of the effects of antibiotic combinations on resistant Staphylococcus aureus mutants: in vitro model studies with linezolid and rifampicin. Journal of chemotherapy (Florence, Italy) 29 (4) (2016)